Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Kidney cancer, Renal cell cancer
Closed
Phase 2
This trial is looking at a drug called V940 in combination with pembrolizumab for renal cell cancer.
It is open to people who have had surgery to remove their cancer and have not had any other treatment after their operation.
Recruitment start: 5 July 2024
Recruitment end: 13 March 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Bala Venugopal
Merck Sharp & Dohme LLC
Last reviewed: 21 April 2025
CRUK internal database number: 19930
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
